HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Albert Faro Selected Research

Therapeutics

4/2024Cystic Fibrosis Foundation Evidence-Based Guideline for the Management of CRMS/CFSPID.
1/2023Prevalence of unmet pain and symptom management needs in adults with cystic fibrosis.
1/2022Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study.
1/2012New developments in treatment after lung transplantation.
6/2008Increased mortality after pulmonary fungal infection within the first year after pediatric lung transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Albert Faro Research Topics

Disease

21Cystic Fibrosis (Mucoviscidosis)
04/2024 - 01/2006
7Infections
01/2022 - 04/2003
6Lung Diseases (Lung Disease)
04/2024 - 06/2007
4Bronchiolitis Obliterans
01/2022 - 10/2009
3Virus Diseases (Viral Diseases)
01/2022 - 10/2009
2Pain (Aches)
11/2023 - 01/2023
2COVID-19
01/2022 - 01/2020
2Fungal Lung Diseases
11/2017 - 06/2008
1Metabolic Syndrome (Dysmetabolic Syndrome X)
04/2024
1Anemia
01/2022
1Body Weight (Weight, Body)
01/2022
1Inflammation (Inflammations)
01/2022
1Pseudomonas Infections
01/2022
1Disease Progression
01/2022
1Hemoptysis
11/2020
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2017
1Congenital Deficiency of Pulmonary Surfactant Protein B
01/2017
1Inborn Genetic Diseases (Disease, Hereditary)
01/2017
1Hypertension (High Blood Pressure)
01/2017
1Persistent Infection
01/2012
1Bone Marrow Failure Disorders
06/2011
1Aplastic Anemia (Anemia, Hypoplastic)
06/2011
1Dyskeratosis Congenita (X-Linked Dyskeratosis Congenita)
06/2011
1Pulmonary Fibrosis (Fibrosing Alveolitis)
06/2011
1Cytomegalovirus Infections (Inclusion Disease)
10/2009
1Viremia
10/2009
1Liver Diseases (Liver Disease)
06/2007
1Pneumonia (Pneumonitis)
04/2003
1Renal Insufficiency (Renal Failure)
04/2003

Drug/Important Bio-Agent (IBA)

4Anti-Bacterial Agents (Antibiotics)IBA
04/2024 - 04/2003
2Oxygen (Dioxygen)IBA
01/2022 - 11/2020
1Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA
04/2024
1CytokinesIBA
01/2022
1ivacaftor drug combination tezacaftorIBA
01/2022
1dornase alfa (Pulmozyme)FDA Link
01/2022
1Hemoglobins (Hemoglobin)IBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
1elexacaftorIBA
01/2022
1COVID-19 VaccinesIBA
01/2021
1Surface-Active Agents (Surfactants)IBA
01/2017
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2016
1ivacaftorIBA
12/2014
1Ganciclovir (Cytovene)FDA LinkGeneric
10/2009
1GlobulinsIBA
10/2009
1cytomegalovirus-specific hyperimmune globulinIBA
10/2009
1Immunoglobulins (Immunoglobulin)IBA
10/2009
1Tobramycin (Nebcin)FDA LinkGeneric
04/2003
1SolutionsIBA
04/2003

Therapy/Procedure

19Lung Transplantation
01/2022 - 12/2003
5Therapeutics
04/2024 - 06/2008
5Palliative Care (Palliative Therapy)
11/2023 - 01/2020
5Transplantation
11/2023 - 12/2003
2Critical Care (Surgical Intensive Care)
11/2020 - 01/2020
1Liver Transplantation
08/2023
1Terminal Care (Care, Terminal)
09/2017
1Operative Surgical Procedures
01/2016
1Hematopoietic Stem Cell Transplantation
06/2011
1Artificial Respiration (Mechanical Ventilation)
02/2007
1Positive-Pressure Respiration (Positive End-Expiratory Pressure)
04/2003